| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1-antitrypsin deficiency: relationship to lung function and health status
1 Antitrypsin Deficiency Assessment and Programme for Treatment (ADAPT) project, Lung Investigation Unit, Queen Elizabeth Hospital, Birmingham, UK and 2 School of Maths and Statistics, Birmingham University, Birmingham, UK
CORRESPONDENCE: R.A. Stockley, Dept of Medicine, Queen Elizabeth Hospital, University Hospital Birmingham NHS Trust, Birmingham, B15 2TH, UK. Fax: 44 1216978256
Keywords: 
1-antitrypsin deficiency, computed tomography, health status, obstructive lung disease, pulmonary emphysema, respiratory function tests
Received: June 22, 2000
Accepted January 18, 2001
 |
Abstract |
|---|
 TOP Abstract MethodsResultsDiscussionAcknowledgementsReferences |
|---|
In order to determine the clinical impact of changes seen on high-resolution computed tomography (HRCT), the relationship between the objective quantification of emphysema on HRCT, lung function and health status in 111 patients with 1-antitrypsin deficiency was examined (PiZ).
The degree of HRCT scan abnormality correlated well (p<0.001 for all comparisons) with forced expiratory volume in one second (r=–0.60––0.75), specific airway conductance (r=–0.67–0.76), residual volume/total lung capacity (r=0.46–0.58) and transfer factor of the lung for carbon monoxide (r=–0.64––0.81). In addition, the CT scans correlated (p<0.001) with health status as assessed by the St. George's Respiratory Questionnaire (SGRQ total: r=–0.38–0.50) and the Short-Form health survey (e.g. physical functioning: r=–0.39–0.54).
In summary, other workers have shown high-resolution computed tomography to be a sensitive indicator of disease progression. This study confirms the relationship between high-resolution computed tomography and lung physiology, and suggests the relationship is even stronger in patients with predominantly lower zone pan-lobular emphysema than in usual chronic obstructive pulmonary disease. High-resolution computed tomography also relates to patients disability and impairment as defined by health status questionnaires and, therefore, should be considered as an alternative outcome measure particularly in a1-antitrypsin deficiency.
1-antitrypsin deficiency (1-ATD) predisposes to the development of emphysema and other features of chronic obstructive pulmonary disease (COPD), particularly in smokers 1. Traditionally, as with usual COPD, this group of patients have been characterized and monitored by spirometric measurements including the forced expiratory volume in one second (FEV1). This measurement is simple to obtain, is useful in defining short-term response to therapy and is of prognostic value 2. However, the FEV1 is effort-dependent, suffers from inherent measurement variability and is relatively nonspecific, reflecting many different aspects of lung pathology in patients with COPD. Furthermore, its relative insensitivity to disease progression meant that the numbers of patients required for a sufficiently powered, randomized, placebo-controlled trial of augmentation therapy in 1-ATD, have generally been prohibitive 3. Pulmonary emphysema is defined pathologically and diagnosis in life is difficult since simple radiography is relatively insensitive 4. However, computed tomography (CT), particularly high-resolution computed tomography (HRCT), detects emphysema accurately at a relatively early stage and allows objective measurements of the degree of abnormality to be made 5–7. Several studies have shown that CT scores derived from radiological densitometric data are related to pathological changes 5, 8, 9 and pulmonary physiology (including FEV1) 6, 10, 11 in patients with emphysema. Perhaps more importantly, several studies have demonstrated that CT is a relatively sensitive measure of emphysema progression 12–14.
Subjective measures using health status questionnaires are now widely recognized as important indicators of impairment and disability and are increasingly being incorporated into intervention trials involving patients with COPD. This is partly because they provide information that cannot be attributed to changes in lung function, as demonstrated by consistently weak correlations between these two modes of patient assessment 15–17.
Because of its sensitivity to change 13, CT scanning would be a good surrogate to assess the efficacy of augmentation therapy in 1-ATD. However, in order to support CT scanning as a tool for monitoring emphysema in intervention studies it is important to establish its relationship to other conventional outcomes. This study was, therefore, designed to confirm the relationship between HRCT and lung function in this well-defined group of patients with relatively pure panlobular emphysema and to define the relationship between HRCT and health status.
|
Methods |
|---|
|
TOPAbstractMethodsResultsDiscussionAcknowledgementsReferences |
|---|
1-ATD (PiZ) were assessed. The phenotype was confirmed by analysis of finger prick blood spot (Heredilab, Salt Lake City, UT, USA). The current study was designed to address the relationships between HRCT, physiological impairment and health status in patients with emphysema. Therefore, six patients with clinically significant liver disease were excluded, together with eight patients who had marked macroscopic changes on HRCT that would distort the relationship between the CT quantification of the amount of emphysema present and the physiological and health status measures. These included interstitial changes (n=3), a single giant bulla in otherwise normal lungs (n=2), lung malignancy (n=1) and previous single lung transplant (n=2). The remaining 111 subjects included 85 index cases and 26 identified by family screening. All subjects were assessed in the stable clinical state at least 2 months after any acute exacerbation. The programme was approved by the University Hospital Birmingham National Health Service Trust ethics committee and all subjects gave informed consent.
Computed tomography
HRCT scanning was performed using a GE Pro Speed Scanner (General Electric Medical Systems, Milwaukee, USA). Slices of 1 mm were taken at 10 mm intervals throughout the thorax, during breath-holding at full inspiration with the subjects in the supine position. The examination was repeated during full expiration at 30 mm intervals, beginning 30 mm above the aortic arch and progressing caudally. Scans were examined visually for the purpose of quality control and in order to assess the presence of macroscopic changes of emphysema 18. Objective quantification of the extent of emphysema was obtained by determining the relative area of pixels representing lung tissue with a density below –910 Hounsfield Unit (HU). This threshold was selected, based on the available published data comparing conventional CT with pathological 9, 11 and physiological 10 assessment of emphysema. The resulting pixel index was determined for a single slice at the level of the aortic arch (upper zone) and the inferior pulmonary vein (lower zone).
Pulmonary physiology
Full lung function testing was carried out on the same day as the clinical assessment and after administration of the health status questionnaires. Dynamic flow rates were determined using wedge-bellows spirometry (Vitalograph Ltd, Buckinghamshire, UK) after the patients had refrained from using bronchodilators for an appropriate period (6 h for short-acting preparations and 12 h for longer-acting preparations). Bronchodilator reversibility was then assessed by repeating flow rates, 30 min after nebulized salbutamol (5 mg) or terbutaline (5 mg) if that was their usual therapy. Patients then received nebulized ipratropium bromide (0.5 mg) and the tests were repeated after a further 30 min to assess any individual or added response to the anticholinergic agent. Lung volumes were determined by helium dilution and gas transfer by the single breath carbon monoxide technique (TL,CO) corrected for effective alveolar volume (KCO). The majority of subjects (n=99) also had airway resistance measured by constant volume plethysmography (Autolink, Morgan Medical, Kent, UK) from which specific airways conductance (sGaw) was calculated. A flow/volume loop was also recorded using a pneumotachograph with a timing facility (Autolink, Morgan Medical, Kent, UK) from which the forced midexpiratory flows (FEF25%–75%) were obtained in order to evaluate small airways disease (n=105). All tests were performed according to British Thoracic Society/Association of Respiratory Technicians and Physiologists guidelines 19.
Health status
Indices of health status were obtained using questionnaires administered by a member of the research team with the patient well rested and prior to pulmonary function testing. The data was collected directly onto a computerized database from which the patient was able to select one of the permitted responses for each item.
The St. George's Respiratory Questionnaire (SGRQ) 15 is a disease specific measure containing 76 items divided into three domains: symptoms (relating to cough, sputum production, wheeze and breathlessness), activity (relating to physical activity limited by breathlessness) and impacts (relating to employment, control, panic, stigmatization, medication and expectations). The responses to each item are empirically weighted according to estimates of the distress caused, resulting in scores 0–100 for each domain with 0 indicating no impairment. A summary score (total) was derived from the responses to the three domains and also scored 0–100.
The Short-Form health survey (SF-36) is a generic measure that assesses health concepts representing basic human values that are relevant to functional status and well being 20. It includes one multidimensional scale measuring each of eight health concepts: physical functioning, role limitations due to physical health problems (role physical), bodily pain, general health, vitality (energy/fatigue), social functioning, role limitations due to emotional problems (role emotional), and mental health (psychological distress and well being). The data was again transformed to a 0–100 scale separately for each health concept, where a score of 0 indicates the most severe disability.
Statistical analysis
The data was analysed using a computerized statistical package (Statistical Package for the Social Sciences (SPSS) version 8.0, SPSS Inc., Chicago, USA). The overall frequency distributions of most of the variables analysed were non-normal and hence the median and interquartile ranges were used to describe the data. Differences between subgroups were determined by the Mann-Whitney U-test for continuous data and Chi-squared test for categorical data. Differences in paired variables required the Wilcoxon signed rank test and correlations between paired variables were examined using Spearman's rho. A p-value <0.05 was taken as statistically significant for all analyses.
|
Results |
|---|
|
TOPAbstractMethodsResultsDiscussionAcknowledgementsReferences |
|---|
. Of the 82 patients (74%) with a history of >1 pack-yr cigarette consumption, nine continued to smoke. The median number of pack-yrs of tobacco consumption amongst the current and exsmokers was 23 (range 2–66).
|
shows the range of pixel indices for the patients with and without macroscopic evidence of emphysema on visual inspection of the HRCT films and demonstrates that the two groups are separated, most notably on the expiratory scans (p<0.001 for all comparisons). The group of 21 subjects with no macroscopic evidence of emphysema on CT were younger compared to those with macroscopic emphysema (median age, 39 versus 51 yrs, respectively, p=0.001). They also included a higher percentage of never-smokers (62% versus 17%, p<0.001) and nonindex cases (71% versus 12%, p<0.001). As expected, their pulmonary function and health status was better than the patients with macroscopic emphysema (p<0.01 for all measures of pulmonary function, and all domains of the SGRQ (data not shown)).
|
) with a good correlation between the severity of emphysema seen (r=0.74–0.79; p<0.001). However, as a group, the pixel indices were higher in the lower zones indicating more extensive emphysema in this region (p<0.001) (fig. 2).
|
). Eighty-three patients (75%) had airflow obstruction as determined by an FEV1<80% predicted and an FEV1/vital capacity ratio <0.7. The median prebronchodilator FEV1 for these subjects was 0.78 L (interquartile range (IQR) 0.63–1.11) which increased to 0.91 L (IQR 0.76–1.44) following ß2-agonist (p<0.001) and 1.08 L (IQR 0.83–1.47) following the addition of ipratropium bromide (p<0.001).
Health status
The SGRQ and SF-36 indicated a wide range of health status, from normal to markedly reduced. The median values for the SGRQ suggested moderate-to-severe impairment from respiratory problems (symptoms: 72.8, normal range 9–15; activity: 73, normal range 7–12; impacts: 40.2, normal range 1–3; total: 55.5, normal range 5–7) and this was accompanied by marked abnormality in the SF-36 domains relating to physical activity and general well being (physical functioning: 40; role physical: 50; general health: 25; vitality: 40) with a milder reduction in social functioning (median 75). The scores for the remaining domains relating to bodily pain, emotional and mental health problems were similar or better than the scores of the general population 20 (data not shown).
Relationship of high-resolution computed tomography to lung function
The pixel indices obtained from all HRCT scans showed highly significant correlations (p<0.001) with all physiological indices. The correlations between HRCT scans and lung function as well as the individual data for FEV1 are shown in table 2, sGaw sGaw and TL,CO are summarized in figure 3.
|
|
. Figure 4 summarizes the health status expressed as total SGRQ score related to bands of pixel index divided according to severity from normal (pixel index<5%) to the presence of extensive emphysema (pixel index>50%). The data confirms the wide scatter of scores but demonstrates a significant decrease in health status for each band of pixel index. This relationship was maintained for both inspiratory and upper zone scans (data not shown).
|
|
). This relationship was maintained for the physical functioning, general health and social functioning domains of the SF-36 (p<0.04 for all correlations). Individual data for the relationship between SGRQ total and FEV1, sGaw and TL,CO are shown graphically in figure 5.
|
|
Discussion |
|---|
|
TOPAbstractMethodsResultsDiscussionAcknowledgementsReferences |
|---|
1-ATD and predominantly lower zone pulmonary emphysema (fig. 2). In addition, the extent of emphysema relates to impairment and disability as assessed by both disease specific and generic health status questionnaires.
This study represents a comprehensive assessment of subjects with 1-ATD (PiZ) where all investigations have been carried out in a single centre, using the same equipment and staff. The data confirms that the majority of subjects had predominantly but not exclusively lower zone emphysema identified by HRCT scanning. Physiologically, the results indicated marked airflow obstruction, air trapping and a reduction in diffusing capacity. In addition, the reduction in FEF25%–75% and sGaw suggest small airways involvement, although it is not clear whether this represents inflammatory changes in the airways or simply reduced elastic recoil and airway collapse. However, recently published pathological data showing bronchiolar involvement in this group of patients 21 suggested that intrinsic changes in the airways themselves may be of more importance than has been previously thought 22.
In this study, using a threshold of –910 HU, the HRCT pixel index was closely related to all measures of pulmonary function. The expiratory scans were most closely related to markers of airway obstruction and gas trapping, although there was a relatively wide scatter of results reflecting the different anatomical influences on airway diameter. The inspiratory scans were as strongly related to KCO which itself is strongly related to emphysema as assessed by the area of walls of distal airspaces per unit of lung volume 5.
There are several methods for analysing and expressing densitometric data from CT scanning, including mean values, percentiles and different density thresholds. However, consensus has yet to be achieved regarding the most appropriate protocol. A value of –910 HU was chosen as the threshold based on the data available at the time the study was initiated and in the belief that the expiratory phase scans would be the most reproducible. Studies published since then have suggested that other thresholds may be more appropriate, at least for the inspiratory phase scans 8. In addition, there is some uncertainty concerning the ventilatory phase that demonstrates the pathological changes most effectively. In the current study, the inspiratory phase scans demonstrated a wider range of pixel indices than the expiratory scans. Also, a small number of asymptomatic patients with pulmonary function tests within the normal range and a normal HRCT scan macroscopically had abnormally high pixel indices. It is possible that these individuals have early, subclinical emphysema not visible macroscopically or that they represent the tail of a normal distribution of lung density which is known to vary with age and total lung capacity in healthy subjects 23. However, it remains most likely that the use of –910 HU as the threshold for the inspiratory scans, results in the overestimation of the extent of emphysema in these subjects.
In support of this possibility, Gevenois et al. 24 found that –910 HU was the appropriate threshold for determining macroscopic emphysema from expiratory scans but found that the correlation between –950 HU applied to inspiratory HRCT and pathological changes was stronger 8. However, 94% of the patients included in these studies were undergoing surgical resections for lung cancer and by necessity had relatively mild emphysema (median value <10%). It is possible that Gevenois et al. 24 may have found a different threshold to be more appropriate if, as in the current study, a wider range of impairment was examined including patients more likely to be seen and treated for COPD in practice and intervention trials. If –950 HU had been used for the inspiratory scans, specificity for the detection of emphysema may have improved but milder disease may also have been missed.
Nevertheless, despite the limited slice protocol and absence of respiratory gating in the current study, the correlations between CT emphysema scores and lung were at least as strong and frequently stronger than those previously noted in usual COPD 10, 11, 24–26. There may be several reasons for this, including the wide range of disease severity studied, the relatively young age group, the use of high-resolution rather than conventional CT, and the fact that all investigations were carried out in a single centre using the same equipment and staff. Also, patients with 1-ATD represent a relatively homogenous group of subjects with pan-lobular emphysema rather than patients with nondeficient COPD where centrilobular emphysema predominates or may even be absent. In addition, as demonstrated in figure 2, the lower lobes are affected predominantly in 1-ATD and there is some evidence that this may have a proportionally greater physiological impact 27, 28.
Although these results do not indicate that the method of CT analysis used in this study is superior to methods used by other workers, it does confirm the usefulness of this approach in the objective assessment of emphysema. However, it is clear that in order to allow comparison between different centres and to facilitate multicentre studies, a consensus is required concerning the most appropriate method. It may be that the aims of individual studies should be taken into account when selecting a CT density threshold. For instance, if the aim is to monitor progression of emphysema in patients with relatively mild disease, then the sensitivity provided by using a more dense threshold may be preferred over the specificity of a lower one. However, further studies are clearly required to explore this possibility.
The development and validation of health status tools have enabled them to become an increasingly important part of disease assessment. Such measures are reproducible and sensitive to change. In studies of COPD patients, FEV1 relates to health status but accounts for only a minor proportion (<10%) of the disability encountered 15, 16, 29, 30. The current study is the first to explore the relationship between emphysema (as assessed by HRCT) and health status. The data showed a clear relationship between the pixel index and the disease-specific SGRQ scores as well as many of the domains of the generic SF-36. However, the relationship between lung function and health status was even stronger. Again, the correlation coefficients indicated stronger relationships than those previously noted in COPD not due to 1-ATD 16–18 and may reflect the homogeneity of the group studied as indicated earlier.
In summary, the current study confirms that high-resolution computed tomography is closely related to physiological changes in patients with emphysema and 1-antitrypsin deficiency. Despite the theoretical limitations of the relatively simple protocol employed here, the correlations are stronger than those observed in previous studies and importantly, involved a lower dose of radiation. This may be of particular importance if computed tomography fulfils its promise as a method for monitoring disease progression and the effects of medical intervention. Furthermore, if an intervention is shown to influence disease progression as assessed by high-resolution computed tomography, the current data suggests that this will not only be associated with preservation of lung function, but also benefits in terms of health status. Although discrepancies between the present data and data from studies in usual chronic obstructive pulmonary disease suggest caution when applying these conclusions more generally, the current study suggests further studies are required to determine whether high-resolution computed tomography can be considered an appropriate outcome measure in addition to or even replacing forced expiratory volume in one second or health status.
|
Acknowledgements |
|---|
|
TOPAbstractMethodsResultsDiscussionAcknowledgementsReferences |
|---|
|
References |
|---|
|
TOPAbstractMethodsResultsDiscussionAcknowledgementsReferences |
|---|
This article has been cited by other articles:
|
|
 |
|
  M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers Eur. Respir. J., February 1, 2008; 31(2): 416 - 469. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Holme and R. A. Stockley Radiologic and Clinical Features of COPD Patients With Discordant Pulmonary Physiology: Lessons From {alpha}1-Antitrypsin Deficiency Chest, September 1, 2007; 132(3): 909 - 915. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. Parr, P. A. Dawkins, and R. A. Stockley Computed tomography: a new gold standard for the clinical assessment of emphysema. Am. J. Respir. Crit. Care Med., October 15, 2006; 174(8): 954 - 954. [Full Text] [PDF]
|
|
|
|
|
|
G. Camiciottoli, M. Bartolucci, N. M. Maluccio, C. Moroni, M. Mascalchi, C. Giuntini, and M. Pistolesi Spirometrically Gated High-Resolution CT Findings in COPD: Lung Attenuation vs Lung Function and Dyspnea Severity Chest, March 1, 2006; 129(3): 558 - 564. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Parr, B. C. Stoel, J. Stolk, and R. A. Stockley Pattern of Emphysema Distribution in {alpha}1-Antitrypsin Deficiency Influences Lung Function Impairment Am. J. Respir. Crit. Care Med., December 1, 2004; 170(11): 1172 - 1178. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S B Shaker, T Stavngaard, J Stolk, B Stoel, and A Dirksen {alpha}1-Antitrypsin deficiency {middle dot} 7: Computed tomographic imaging in {alpha}1-antitrypsin deficiency Thorax, November 1, 2004; 59(11): 986 - 991. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R A Stockley The HRCT scan pursuing real life pathology Thorax, October 1, 2004; 59(10): 822 - 823. [Full Text] [PDF]
|
|
|
|
|
|
I. S. Patel, I. Vlahos, T. M. A. Wilkinson, S. J. Lloyd-Owen, G. C. Donaldson, M. Wilks, R. H. Reznek, and J. A. Wedzicha Bronchiectasis, Exacerbation Indices, and Inflammation in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., August 15, 2004; 170(4): 400 - 407. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.D. Newell Jr, J.C. Hogg, and G.L. Snider Report of a workshop: quantitative computed tomography scanning in longitudinal studies of emphysema Eur. Respir. J., May 1, 2004; 23(5): 769 - 775. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P A Dawkins, L J Dowson, P J Guest, and R A Stockley Predictors of mortality in {alpha}1-antitrypsin deficiency Thorax, December 1, 2003; 58(12): 1020 - 1026. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Ferrarotti, M. Zorzetto, M. Beccaria, L.S. Gile, R. Porta, N. Ambrosino, P.F. Pignatti, I. Cerveri, E. Pozzi, and M. Luisetti Tumour necrosis factor family genes in a phenotype of COPD associated with emphysema Eur. Respir. J., March 1, 2003; 21(3): 444 - 449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Luisetti, M. Miravitlles, and R.A. Stockley {alpha}1-antitrypsin deficiency: a report from the 2nd meeting of the Alpha One International Registry, Rapallo (Genoa, Italy), 2001 Eur. Respir. J., October 1, 2002; 20(4): 1050 - 1056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. DOWSON, P. J. GUEST, and R. A. STOCKLEY Longitudinal Changes in Physiological, Radiological, and Health Status Measurements in alpha 1-Antitrypsin Deficiency and Factors Associated with Decline Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1805 - 1809. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.G. Cosio and G.L. Snider Chest computed tomography: is it ready for major studies of chronic obstructive pulmonary disease? Eur. Respir. J., June 1, 2001; 17(6): 1062 - 1064. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
, n=90) and without (
, n=21) macroscopic evidence of emphysema on visual reporting. The median (horizontal bar), interquartile range (box) and range (whiskers) are displayed for each group. Outliers (values >1.5 box lengths away from the top or bottom of the box) are not displayed. The PI for the scans from subjects with emphysema is significantly greater (p<0.001) for all scans. HU: Hounsfield Units.
